SCHEMBL19081656

SCHEMBL19081656

c1ccc2c(-c3c4ccccc4c(-c4ccc5cc(-c6ccc7oc8c(ccc9oc%10ccc%11ccccc%11c%10c98)c7c6)ccc5c4)c4ccccc34)cccc2c1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.36
CYP1A1 P04798 2/20 0.35
CYP1B1 Q16678 1/20 0.35
ABCG2 Q9UNQ0 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
AHR P35869 3/20 0.34
PAX8 Q06710 2/20 0.34
MEN1 O00255 2/20 0.34
MAPT P10636 2/20 0.34
KMT2A Q03164 2/20 0.34
CYP1A2 P05177 1/20 0.34
FYN P06241 1/20 0.34
MAPK3 P27361 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
TP53 P04637 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP2D6 P10635 1/20 0.34
CYP2C9 P11712 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19081662 0.93 ALOX5 (0.36) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL17944541 0.93 ALOX5 (0.38) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL19081659 0.92 ALOX5 (0.36) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL19080068 0.91 CYP1A1 (0.35) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL17945167 0.91 ALOX5 (0.41) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL19081657 0.91 CYP1A1 (0.35) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL19109857 0.91 ALOX5 (0.41) ALOX5CYP1A1CYP1B1ABCG2TDP1
SCHEMBL19081585 0.91 CYP1A1 (0.39) CYP1A1CYP1B1ABCG2TDP1L3MBTL1
SCHEMBL19081639 0.91 ALOX5 (0.40) ALOX5CYP1A1ABCG2TDP1L3MBTL1
SCHEMBL17945168 0.91 CYP1A1 (0.43) ALOX5CYP1A1CYP1B1ABCG2TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-02-04 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10553800-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885
US-20170194572-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNT1 ALOX5 1939/4885CYP1A1 184/4885CYP1B1 260/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.